Irving Kahn has just celebrated his 106th birthday. He still works at his brokerage and money-management firm with his son and refuses to take vacations. His sister Helen, better known as Happy, has just died only weeks shy of her 110th birthday. Leonore Kahn died relatively young at 99 and Peter continues to live, although blind, after 101 years. With cooperation from the Kahn siblings and other “SuperAgers”, people over 95 who have yet to have cardiovascular disease, cancer, diabetes, or serious cognitive decline, Barzilia has found genes which are likely to play a large role in longevity. Multiple drug companies are now experimenting with ways of allowing those who are genetically less fortunate to reap the benefits of great DNA, but some question whether the additional years are worth living.
“…if you lose your eyesight, you are 99 percent dead” explained Peter, who was blinded by glaucoma and macular degeneration in 2007. Even in relatively good health, especially for his age, Peter is depressed. Living with parents who are nearing sixty, I can see the downside of being old, whether old is fifty or 100 years old. Of course this is not a reason to stop living when your first grey hair sprouts, but I would take this into consideration before attempting to increase my lifespan with gene therapy. However, the counterargument is nearly all medical treatments aim to increase lifespan in some fashion and the treatments which may be developed as a result of Dr. Barzilia’s research are no different. I can see both sides and I would need more specifics before making a decision.
Article: http://nymag.com/news/features/ashkenazi-jews-2011-11/
Related: http://www.nytimes.com/2011/09/22/science/22longevity.html
No comments:
Post a Comment